Publication | Closed Access

PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

MedicineHuman RetrovirusImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugHivPharmacologyAntiviral Compound